spacer
spacer

PDBsum entry 3w9f

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transport protein PDB id
3w9f

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
255 a.a.
Ligands
I3P ×4
Waters ×461
PDB id:
3w9f
Name: Transport protein
Title: Crystal structure of the ankyrin repeat domain of chicken trpv4 in complex with ip3
Structure: Vanilloid receptor-related osmotically activated channel protein. Chain: a, b, c, d. Fragment: unp residues 133-382. Engineered: yes
Source: Gallus gallus. Bantam,chickens. Organism_taxid: 9031. Gene: trpv4, vr-oac. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
1.90Å     R-factor:   0.219     R-free:   0.246
Authors: Y.Itoh,S.Hamada-Nakahara,S.Suetsugu
Key ref: N.Takahashi et al. (2014). TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P₂. Nat Commun, 5, 4994. PubMed id: 25256292 DOI: 10.1038/ncomms5994
Date:
04-Apr-13     Release date:   09-Apr-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
A0A1D5PXA5  (TRPV4_CHICK) -  Transient receptor potential cation channel subfamily V member 4 from Gallus gallus
Seq:
Struc:
 
Seq:
Struc:
852 a.a.
255 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 5 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1038/ncomms5994 Nat Commun 5:4994 (2014)
PubMed id: 25256292  
 
 
TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P₂.
N.Takahashi, S.Hamada-Nakahara, Y.Itoh, K.Takemura, A.Shimada, Y.Ueda, M.Kitamata, R.Matsuoka, K.Hanawa-Suetsugu, Y.Senju, M.X.Mori, S.Kiyonaka, D.Kohda, A.Kitao, Y.Mori, S.Suetsugu.
 
  ABSTRACT  
 
Mutations in the ankyrin repeat domain (ARD) of TRPV4 are responsible for several channelopathies, including Charcot-Marie-Tooth disease type 2C and congenital distal and scapuloperoneal spinal muscular atrophy. However, the molecular pathogenesis mediated by these mutations remains elusive, mainly due to limited understanding of the TRPV4 ARD function. Here we show that phosphoinositide binding to the TRPV4 ARD leads to suppression of the channel activity. Among the phosphoinositides, phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) most potently binds to the TRPV4 ARD. The crystal structure of the TRPV4 ARD in complex with inositol-1,4,5-trisphosphate, the head-group of PI(4,5)P2, and the molecular-dynamics simulations revealed the PI(4,5)P2-binding amino-acid residues. The TRPV4 channel activities were increased by titration or hydrolysis of membrane PI(4,5)P2. Notably, disease-associated TRPV4 mutations that cause a gain-of-function phenotype abolished PI(4,5)P2 binding and PI(4,5)P2 sensitivity. These findings identify TRPV4 ARD as a lipid-binding domain in which interactions with PI(4,5)P2 normalize the channel activity in TRPV4.
 

 

spacer

spacer